Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Recruiting · NCT06483555 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, basal cell neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-04-23 | NCT06483555 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 125 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 3 |